Skip to content

Decoy Therapeutics Inc.

DCOY

CIK 0001615219

← back to feed
Revenue (TTM)
$0
−100.0% YoY Q1 May 2026
Net Income (TTM)
−$5.77M
−124.5% YoY Q1 May 2026
EPS Diluted (TTM)
−$246.51
−85.6% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$8.75M
Q1 May 2026
Cash
$7.82M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
531.97K sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings